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treatment	 is	 surgical	 implantation	 of	 an	 intra-ocular	 lens.	 Due	 to	 the	 number	 of	
annual	 surgeries	 this	 approach	 is	 expensive	 and	 can	 result	 in	 a	 range	 of	 sight-
affecting	complications.	Difficulties	arise	 in	accessing	vision-restoring	surgery	 for	
people	 with	 cataract	 living	 in	 developing	 countries	 due	 to	 inadequate	 access	 to	
cataract	 surgery.	 Greater	 understanding	 of	 cataract	 molecular	 mechanisms	 is	
required	for	development	of	anti-cataract	drugs	that	may	be	easier	to	access	than	
surgery.	Several	cataract	risk	factors	have	been	postulated;	however,	their	specific	
molecular	 mechanisms	 are	 poorly	 identified.	 This	 is	 due	 largely	 to	 a	 lack	 of	
functional	human	lens	tissue	available	for	studying	cataract.	Previous	investigations	
of	 cataract	 have	 used	 animal	 models	 to	 study	 lens	 development	 and	 cataract;	
however,	 there	 are	 significant	 differences	 between	 humans	 and	 animal	 lenses	
including	protein	expression	and	cell	membrane	composition.	Human	pluripotent	
stem	(PS)	 cells	 are	a	potential	 source	of	human	 lens	 cells	 and	an	elegant	3-stage	
protocol	 for	 generating	 lens	 cells	 and	 rudimentary	 lens	 tissue	 was	 published	 in	
2010.	Several	groups	have	attempted	to	refine	this	protocol	with	varying	success.	
Nevertheless,	all	of	these	approaches	suffer	from	three	main	issues:	i)	production	of	
heterogeneous	 cultures	 of	 human	 lens	 and	 non-lens	 cells;	 ii)	 poorly-	 or	
uncontrolled-production/loss	 of	 rudimentary	 lens	 tissue;	 and	 iii)	 limited	 or	 no	








uniform,	 transparent	 and	 light-focusing	 human	 PS	 cell-derived	 lens	 organoids,	
termed	micro-lenses.	These	micro-lenses	appear	able	to	model	a	clinically-relevant	
cataract	 associated	 with	 exposure	 to	 the	 cystic	 fibrosis	 drug	 Vx-770.	 These	
functional	 human	 micro-lenses	 represent	 a	 useful	 tool	 for	 drug	 discovery	 and	
toxicity.	
In	 addition	 to	 the	 successes	 of	 producing	 the	 world-first	 human	 PS	 cell-derived	
micro-lenses,	 there	 were	 several	 lessons	 learned	 during	 this	 project.	 Repeated	
failures	of	the	cells	to	survive	and	proliferate	on	RGDS-chitosan	film	negated	some	







derived	 micro-lenses.	 Furthermore,	 the	 rapid	 assessment	 lesson	 learned	 by	
experiencing	 some	unworkable	 situations	 in	 the	 course	 of	 the	 project	were	 then	















The	eye’s	 lens	must	be	transparent	with	a	high	refractive	 index	 in	order	to	 focus	
light	 onto	 the	 retina.	 Cataract	 is	 a	 pathological	 condition	 that	 results	 in	 loss	 of	
transparency	due	to	increased	light	scatter	in	the	lens,	resulting	in	impaired	vision	
or	blindness.	Cataract	is	prevalent	in	our	ageing	population	and	the	leading	cause	of	
preventable	 blindness	 worldwide	 (1).	 Cataract	 accounts	 for	 35%	 of	 blindness	






Currently,	 the	 only	 treatment	 available	 for	 cataract	 is	 surgical	 implantation	 of	 a	
plastic	intra-ocular	lens	(IOL),	and	this	surgery	is	increasing	in	demand	by	an	ageing	
population.	 Cataract	 surgery	 is	 one	 of	 the	 most	 commonly	 performed	 surgical	
procedures	in	the	world	yet	the	current	levels	of	surgery	are	too	low	to	cope	with	
the	 load	of	patients	with	cataract	(3).	Additionally,	due	to	population	ageing,	 it	 is	
expected	that	there	will	be	and	increased	demand	for	cataract	surgeries;	the	number	
of	people	with	moderate	to	severe	visual	impairment	due	to	cataract	is	expected	to	
increase	 by	 8%	between	 2015	 to	 2020	 (2)	 due	 to	 increased	 life	 expectancy	 and	
growth	 in	 ageing	 populations	 (4).	 The	World	 Health	 Organization	 (WHO)	 global	
action	plan	(5)	aims	to	decrease	preventable	blindness	by	25%	between	2010	and	
2019,	prioritizing	cataract	(4).	Countries	with	a	low	human	development	index	and	















posterior	 capsule	opacification	 (PCO)	 is	 a	 common	side-effect	 that	often	appears	
after	 2	 or	 more	 years	 in	 a	 large	 number	 of	 patients	 and	 requires	 additional	
treatment	 to	maintain	visual	acuity.	The	costs	of	 treating	cataract	worldwide	are	
increasing	annually	due	to	an	increasing	ageing	population	(4).	The	direct	cost	of	
cataract	 treatment	 was	 $326	 million	 in	 Australia	 in	 2004	 (1).	 Internationally,	
billions	 of	 dollars	 are	 spent	 each	 year	 on	 cataract	 surgery.	 Identification	 of	 risk	




















cataract	 can	 also	 occur	 with	 devastating	 effects,	 particularly	 on	 the	 social	 and	
intellectual	development	of	 the	patient	(10).	Pediatric	cataract	 is	one	of	 the	most	
common	causes	of	blindness	in	children,	particularly	in	the	developing	world	(18).	
Early	 recognition	 and	 treatment	 of	 lens	 opacity	 is	 essential	 to	 avoid	 deprivation	
amblyopia	 (18)	 whereby	 loss	 of	 vision	 in	 critical	 neurological	 developmental	
periods	 can	 cause	 permanent	 blindness.	 Congenital	 cataract	 requires	 early	
intervention	to	prevent	amblyopia	and	surgery	often	takes	place	as	early	as	8	to	12	
weeks	of	age	(19).	Infants	may	be	implanted	with	an	IOL	at	this	stage	(if	access	to	
follow-up	 surgery	 is	 limited;	 in	 these	 cases,	 the	 children	 require	 corrective	
spectacles	 initially	before	 the	child	 ‘grows	 into’	 the	corrective	power	of	 the	 IOL).	
Alternately,	 and	 more	 typically	 in	 developed	 countries,	 the	 childhood	 cataract	
patient	does	not	undergo	IOL	implantation	after	cataract	removal.	Instead,	the	child	
remains	aphakic	for	up	to	2	to	10	years	to	allow	the	child’s	eye	to	grow.	During	this	






1.1.1 Cataract risk factors 
Cataract	can	be	classified	in	a	number	of	ways,	including	the	location	in	the	lens	and	
the	 characteristics	 of	 the	 opacified	 area.	 The	most	 common	 cataract	 type	 is	 age-
related	 nuclear	 cataract	 (ARN)	 (21,22).	 Other	 types	 of	 cataract	 such	 as	 cortical	
cataract	 demonstrate	 a	 variety	 of	 forms	 including	 radial,	 dot	 and	 spoke	 shaped	
opacities	(23).	Multiple	cataract	risk	 factors	(Table	1.1)	have	been	postulated	 for	






in	 the	 lens	 (23,29).	 Single	 nucleotide	 polymorphisms	 (SNPs)	 have	 also	 been	
correlated	 with	 cataract	 in	 gene-gene	 and	 gene-environmental	 analyses	 (30).	
Difficulties	 arise	 in	 determining	 the	 causative	mechanisms	 of	 cataract	 in	 human	
lenses	 due	 to	 severe	 difficulties	 in	 accessing	 useful	 quantities	 of	 intact/non-








Table 1.1 Cataract types and risk factors 
Risk factor Type Proposed mechanism 
metal ion and tryptophan 
metabolites (31) nuclear crystallin cross-linking 
cigarette smoking 
(32,33) nuclear, posterior subcapsular metal ions 
hyperglycaemia 
(34,35) 
nuclear, posterior subcapsular, 
cortical glycation of crystallin 
radiation: UV, electromagnetic, 
ionizing (36-38) posterior subcapsular, cortical 
includes instantaneous, long 
and short-term exposure 
drugs (39) posterior subcapsular long term use of corticosteroids 
alcohol (40) age-related 
cytochrome-induced oxidation 
/ 
increased Ca permeability 
age (41) age-related nuclear multilamellar bodies 
age (42) age-related post-translational modification - methylation 
multifactorial (32) age-related both multiple genes and environmental factors 
oxidative stress (29,43) age-related miRNA regulation of oxidative stress genes, Maillard reaction 
altered crystallin 
transcriptional activity (30,44) age-related 
CRYAA polymorphisms SNPs 








and	 available	 in	 sufficient	 quantities	 to	 enable	 analysis	 of	 multiple	 replicates	 of	
exposure	to	suspected	cataract	causing	agents	via	a	range	of	detection	techniques.	
The	 ability	 to	 test	 cataract	 risk	 factors	 such	 as	 smoking	 (33,45),	 oxidation	
(21,23,33,46,47),	 diabetes	 (34,35),	 electromagnetic	 radiation	 (48-50),	 ageing	








comprehension	 of	 lens	 anatomy,	 molecular	 biology	 and	 development	 and	 have	
provided	 further	 understanding	 of	 human	 lens	 biology.	 The	 following	 section	
reviews	what	is	known	about	these	processes.	
 23 
1.2.1 Lens anatomy 
Anatomically,	 the	 lens	 is	 a	 transparent,	 biconvex,	 avascular	 and	 non-innervated	
tissue	located	near	the	anterior	of	the	eye,	posterior	to	the	cornea	and	iris	(Figure	
1.1).	After	light	enters	the	eye	through	the	cornea,	the	lens	focuses	it	onto	the	retina.	
Lens	 function	 is	 intimately	 linked	 to	 its	anatomical	 features.	Postnatally,	 the	 lens	





















establishment	 of	 an	 organelle	 free	 zone	 (OFZ)	 via	 controlled	 degradation	 of	 all	
organelles	 (thereby	 increasing	 lens	 transparency	 by	 removing	 potentially	 light-
scattering	particles	from	the	light	path	of	the	lens	including	the	cell	nucleus)	(58-
60).	 Nuclear	 degradation	 is	 a	 key	 process	 that	 contributes	 to	 maximal	 light	
transmission	and	reduced	light	scatter.	Establishment	of	the	OFZ	occurs	in	the	pre-
natal	 period;	 however,	 this	 process	 has	 not	 been	 well	 documented	 in	 humans	
(60,61).	 Studies	of	 early	 lens	development	have	 relied	mainly	on	 embryonic	 and	
postnatal	 chick,	 or	 mouse	 and	 rat	 lenses	 to	 examine	 nuclear	 and/or	 organelle	










Figure 1.1 Structure of the eye  
A cross-sectional diagram of the eye showing the location of the lens and other primary eye structures, 










Figure 1.2 Structure of the mammalian lens  
This diagram indicates the location of the anterior lens epithelial monolayer, transitional zone where LF 
cell differentiation begins, the lens nucleus (containing the primary LF cells), and the layers of secondary 










contribute	 to	 the	high	 light	 transmission	properties	of	 the	 lens.	 Interestingly,	 the	
crystallin	proteins	of	the	lens	nucleus	are	present	at	birth	and	exist	throughout	life	
without	 being	 replaced	 (as	 terminally	 differentiated	 cells	 have	 lost	 their	
transcriptional	 machinery)	 (65).	 They	 are	 therefore	 amongst	 the	 longest-lived	
proteins	in	the	body	(72).	Likewise,	LF	cells	do	not	turn	over,	and	the	lens	continues	
to	grow	throughout	life	by	addition	of	LF	cell	layers	(52).	The	longevity	of	crystallin	











1.3 Mechanisms of lens development  
1.3.1 Mammalian lens development 
The	structure	of	 the	mature	 lens	described	above	 is	a	consequence	of	a	series	of	
events	that	occur	during	embryonic	development.	In	mammals,	lens	development	
begins	 with	 a	 thickening	 of	 the	 lens	 placode	 (Figure	 1.3),	 a	 section	 of	 surface	
ectoderm	 in	 the	 early	 embryo	 (78).	 The	 cells	 of	 the	 lens	 placode	 proliferate,	
invaginate,	then	close	and	separate	from	the	lens	placode	to	form	the	lens	vesicle	
(78).	Cells	 in	 the	posterior	section	of	 this	 spherical	monolayer	of	 lens	progenitor	
cells	 then	 differentiate	 into	 primary	 LF	 cells	 in	 response	 to	 relatively	 high	
concentrations	 of	 fibroblast	 growth	 factor	 (FGF)	present	 in	 the	 vitreous	humour	
(Figure	1.1)	(75,79,80).	Elongation	of	the	primary	LF	cells	fills	the	lumen	of	the	lens	
vesicle,	 generating	 the	 basic	 lens	 structure.	 Maturation	 of	 the	 primary	 LF	 cells	





other	 species	 (81).	 For	 example,	 transcription	 factors	Pax6	and	 the	 Sox	 family	 is	
conserved	 in	 invertebrates	 such	 as	 Drosophila	 in	 addition	 to	 vertebrates	 and	
mammals	 functioning	 in	 both	 as	 induction	 of	 the	 lens	 placode	 and	 LF	 cell	











1.3.2 Teleost lens development 
Like	 early	 mammalian	 lenses,	 lens	 development	 in	 teleost	 species	 such	 as	 the	





the	 lens	 cell	mass	 differentiate	 to	 form	 primary	 LF	 cells.	 Secondary	 LF	 cells	 are	









Figure 1.3 Comparative development of mammalian and teleost lenses  
The mammalian lens (left) is formed from a thickened lens placode (left, top) that extends and invaginates 
to form a vesicle lined with a monolayer of LECs that differentiate, at the equator of the vesicle, to produce 
LF cells that fill the vesicle (left, bottom). The Zebrafish lens (right) commences development with a 
thickening of the lens placode (right, top) that continues to thicken and form a ball-like mass that 





in	broadly	similar	 lens	structures	and	functions.	 In	the	 laboratory,	 formation	of	a	
lens	 vesicle-like	 structure	 comprised	 of	 paired	 rat	 LEC	 explants	 (Figure	 1.4)	 has	
been	used	to	generate	functional	(Figure	1.5),	physiologically-sized	rat	lenses	(89).	
The	 time	 and	 labor-intensive	 nature	 of	 that	 system	 restricts	 its	 capacity	 to	
generating	 only	 small	 numbers	 of	 rat	 lenses	 in	 vitro	 for	 studies	 of	 cataract	
development	(89).	Also,	it	still	represents	an	animal-based	model	of	lens	function.	A	
simple	 and	 robust	 system	 for	 reproducibly	 generating	 large	 numbers	 of	 light-
focusing	 human	 lenses,	 perhaps	 by	 gaining	 insight	 from	 an	 aspect	 of	 the	 teleost	
developmental	morphology	and	arranging	a	quantity	of	ROR1+	LECs	into	a	spherical	









Figure 1.4 Rat explant pair-based lens regeneration 
Schematic diagram showing how the anterior epithelial monolayer of rat lenses were harvested, trimmed 
to remove partly differentiated equatorial LF cells then paired to simulate the lens vesicle in vitro. 
Placement of the bottom LEC monolayer in contact with the plastic culture dish provided an 







Figure 1.5 Rat lens explant pair produced a lens that had focusing ability 
A light-focusing in vitro rat lens generated from paired rat LEC explants demonstrating the ability of these 




1.4 The necessity for an in vitro human lens model 
Morphological	and	genetic	differences	between	species	mean	that	the	current	use	of	
animal	lens	models	may	be	insufficient	to	address	the	need	for	research	on	human	




a	 human	 lens	model	 that	possesses	 similar	 functional,	 anatomical	 and	molecular	
properties	to	normal	human	lenses	-	particularly	the	ability	to	focus	light	-	as	well	
as	the	ability	to	be	produced	in	large	quantities	could	fulfil	the	need	for	studies	of	
lens	 development,	 assessment	 of	 cataract	 risk	 factors,	 clinically	 relevant	 toxicity	
assays	 and	anti-cataract	drug	 screening.	Candidate	drugs	 that	 can	 cause	 cataract	
could	be	utilized	to	validate	a	lens	tissue	model.		
Encouragingly,	 human	 PS	 cells	 can	 be	 differentiated	 via	 a	 3-stage	 protocol	 into	









1.5 The role of pluripotent stem cells in in vitro lens 
production 
Much	 of	 our	 understanding	 of	 early	 lens	 development	 has	 been	 obtained	 by	
investigating	animal	models	that	have	developmental	and	physiological	similarities	









14	 days	 post-fertilisation)	 (94-96),	 donated	with	 informed	 consent	 from	 in	 vitro	
fertilisation	programs	(97).	Human	ES	cells	are	obtained	from	the	inner	cell	mass	
(94,96)	of	human	blastocysts	5	to	14	days	post	fertilisation.	At	this	stage,	the	embryo	
is	 composed	 of	 the	 trophoblast	 that	 forms	 the	 outer	 layer	 (cytotrophoblast	 for	
attachment	to	the	uterine	wall)	and	placenta	(syncytiotrophoblast),	and	the	inner	
cell	mass	that	undergoes	gastrulation	to	form	the	embryo	(95).	Human	PS	cell	lines	





pluripotent,	 embryonic-like	 state	 by	 forced	 expression	 of	 transcription	 factors	
involved	in	pluripotency	(99,100).	Human	iPS	cells	can	be	used	to	generate	normal	





1.5.1 Production of lens cells from human PS cells in vitro 
The	 3-stage	 growth	 factor	 method	 for	 generating	 heterogeneous	 populations	 of	
LECs	and	subsequently,	LF	cells,	from	human	ES	cells	was	published	in	2010	(Figure	
1.6)	 (90).	 The	 method	 involves	 exposure	 to	 a	 progressive	 sequence	 of	 growth	
factors	 that	 regulate	 cell	 fate	 chosen	 to	 mimic	 aspects	 of	 embryonic	 lens	
development	in	vitro.	The	first	stage	introduces	Noggin	for	6	days	to	inhibit	Bone	
Morphogenic	 Protein	 (BMP)	 signalling	 and	 thus	 differentiate	 the	 human	ES	 cells	
towards	a	neuroectoderm	fate	(90).	The	12-day	long	second	stage	introduces	BMP4	
and	BMP7,	as	well	as	Fibroblast	Growth	Factor	2	(FGF2)	to	induce	production	of	lens	
placodal	 cells	 (i.e.,	 LEC	 progenitor	 cells)	 (90).	 A	 third	 stage	 that	 uses	 FGF2	 and	
WNT3a	stimulates	differentiation	of	LECs	to	LF	cells	(85,90).		
This	3-stage	method	represents	a	simplification	of	the	growth	factor	regulation	of	
the	 lens	 developmental	 process.	 First	 the	 development	 of	 neuroectoderm	 is	
prompted	by	Noggin,	an	antagonist	of	BMP	(102),	followed	by	induction	of	LECs.	The	
growth	factors	FGF	and	BMP	interplay	to	promote	LEC	differentiation,	with	a	low	

























Figure 1.6 Generation of lens cells from human PS cells 
The 3-stage process introduces a sequence of growth factors that stimulate human PS cells towards a 
neuroectoderm fate followed by lens cell production, resulting in a heterogeneous mixture of non-lens 





LF	 cells,	 the	 method	 does	 have	 some	 important	 limitations.	 The	 resulting	 cell	
population	 is	 a	 heterogeneous	 mixture	 of	 LECs,	 LF	 cells	 and	 non-lens	 cells.	 An	














to	 become	 lens	 cells.	 As	 with	 Yang	 et	 al,	 this	 approach	 yielded	 a	 mixed	 cell	
population	of	non-lens	cells,	LECs	and	LF	cells	(90).	Comparably,	Li	and	colleagues	
(93)	 harvested	 cells	 from	 the	 anterior	 LECs	 of	 lenses	 removed	 from	 cataract	
patients.	 These	 cells	 were	 induced	 to	 pluripotency	 then,	 following	 the	 3-stage	
protocol	 (90),	 differentiated	back	 into	 a	 (mixed	population	of)	 LECs	 (93).	Whilst	
these	studies	demonstrated	 the	possibility	of	generating	 lens	cells	 from	 iPS	cells,	
with	 or	 without	 a	 genetic-based	 disease	 state,	 the	 methods	 were	 insufficiently	
developed	 to	 yield	 either	 pure	 LEC	 populations	 or	 produce	 discrete	 and	 light-
focusing	lens	tissue.	
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1.5.2 Improvements to lens cell production from human 
PS cells 
Attempts	 at	 purifying	 lens	 cells	 from	mixed	 cultures	of	 differentiating	human	PS	
cells	 have	 seen	 variable	 success.	 Adopting	 an	 approach	 alternative	 to	 the	 Yang	
method,	 Mengarelli	 and	 Barberi	 (107)	 cultured	 human	 ES	 cells	 in	 insulin-
transferrin-selenium	(ITS)	medium	and	separated	the	resulting	mixture	of	cells	via	
fluorescent	activated	cell	sorting	(FACS).	Adult	lens	surface	markers,	c-Met/HGFR	
and	 CD44	were	 used	 to	 positively	 select	 and	 separate	 lens	 cells	 that	 were	 then	
cultured	(107).	However	further	culture	of	these	cells	revealed	that	the	population	
was	impure	and	included	neuronal	cells	(107).	Furthermore,	the	lens	cell	population	
had	 poor	 survival	 and	 proliferation,	 demonstrating	 the	 necessity	 for	 a	 more	
appropriate	lens	culture	medium	capable	of	retaining	the	morphology	of	the	LECs.	
More	recently,	Fu	and	colleagues	(91),	generated	tens	of	lens-like	tissues	in	a	highly	






bioinformatic	 approach	 (108).	 These	 ROR1+	 LECs	 displayed	 similar	morphology,	
gene	expression	and	protein	expression	to	human	fetal	LECs	(108).	A	subsequent	
combinatorial	 growth	 factor	 screening	 approach	 identified	 a	medium	 capable	 of	
proliferating	the	ROR1+	human	cells	while	maintaining	their	LEC-like	features.	This	








cell	 manipulations	 in	 vitro	 have	 seen	 development	 of	 miniature-sized	 organ	
counterparts	called	organoids.	These	 in	vitro	organoids	resemble	their	full-size	 in	
vivo	counterparts	in	terms	of	cell	type,	cellular	organisation	and	function.	They	have	
become	an	 increasingly	utilized	 tool	 for	 the	 study	of	 organ	development	 and	 for	
producing	 tissues	 for	 disease-in-a-dish	models	 (109).	 Organoids	may	 be	 derived	
from	 tissue	 specific	 adult	 stem	 (AS)	 cells	 (110,111),	 human	 ES	 cells	 or	 iPS	 cells	
(101,112,113).		
Organoids	 have	 been	 developed	 for	 several	 tissue	 types	 thus	 far	 including	 liver	
(114),	brain	(115),	intestine	(116),	lung	(117)	and	kidney	(118-120).	Rudimentary	
eye-related	organoids	have	also	been	developed	 including	 the	 lentoids	described	
above,	as	well	as	 retina	and	optic	cups	 (121).	These	organoids	are	being	used	 to	




organoids	 have	 the	 potential	 to	 be	 useful	 for	 drug	 toxicity	 and	 therapeutic	 drug	
screening,	particularly	if	produced	in	large	quantities	(111).	Due	to	the	specialized	
and	intensive	nature	of	culturing	stem	cell-derived	organoids,	production	of	large	
quantities	 of	 organoids	 is	 not	 always	 possible.	 The	 ability	 to	 simply	 and	
reproducibly	generate	large	numbers	of	 light-focusing	human	lenses	from	human	
PS	cells	in	a	controlled	manner	would	overcome	many	of	the	limitations	inherent	to	
the	 existing	 lens	 differentiation	 protocols,	 thereby	 offering	 detailed	 molecular	
insights	into	human	lens	and	cataract	formation.		
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1.6 Hypothesis and aims  
1.6.1 Hypothesis 
That	aggregation	of	human	PS	cell-derived	purified	ROR1+	LECs	to	mimic	a	teleost	
lens	 cell	mass,	 can	produce	 large	numbers	of	 light-focusing	human	micro-lenses,	
suitable	for	studies	of	lens	development	and	cataract	formation. 
1.6.2 Aims 
1. To	 examine	 whether	 human	 PS	 cell-derived	 purified	 ROR1+	 LECs	 can	
generate	large	numbers	of	functional	micro-lenses	in	vitro.	


















of	 LECs,	 LF	 cells	 and	 non-lens	 cells,	 with	 up	 to	 59%	 of	 cells	 not	 expressing	 αA-
crystallin.	Use	of	such	an	impure	population	of	cells	gives	uncertainty	about	the	cell	
types	 being	 assessed	 and	 the	 responses	 detected	 in	 downstream	 applications.	







to	 improve	the	method	to	produce	more	normal	 lens-like	tissues	 from	human	PS	
cells	(91-93).		
A	 useful	 system	 for	 studying	 lens	 development	 or	 for	 high-throughput	 drug	










2.1.2 Mimicking cross-species development to produce an 




exposed	 to	 a	 gradient	 of	 growth	 factors	 (including	 FGF	 signaling)	 (75,124)	 that	
polarise	the	lens	to	produce	an	anterior	LEC	monolayer	and	a	large	posterior	fiber	
cell	compartment.		
A	 previous	 attempt	 at	 an	 in	 vitro	 lens	 generation	 by	 our	 group	 revealed	 that	 by	
mimicking	aspects	of	embryonic	lens	development	in	vitro,	production	of	correctly	
organized,	light	focusing	lens	tissue	was	possible	(89,125).	Key	lens	features	of	the	
rat	 LEC-derived	 ‘paired	 explant’	 in	 vitro	 lenses	 included	 transparency,	 light	
focussing,	 expression	 of	 mature	 lens	 proteins,	 β-crystallin	 and	 γ-crystallin	 and	
organelle	loss	consistent	with	terminal	LF	cell	differentiation.	The	rat	lens	explant	
pair	 demonstrated	 that	 taking	 an	 approach	 that	 replicated	 mammalian	 lens	
development	 in	 vitro	 was	 sufficient	 to	 produce	de	 novo	 lens	 tissue.	 However,	 as	
mentioned	above,	 the	manual	nature	of	 this	process	means	 it	 is	not	amenable	 to	
generation	of	large	numbers	of	lenses	for	high-throughput	studies.	While	a	method	
for	 generating	 large	 numbers	 of	 mouse	 lens	 vesicles	 in	 vitro	 has	 recently	 been	
developed,	this	process	is	highly	complex	and	time	consuming	(126).	Interestingly,	
differences	 in	early	developmental	pathways,	 as	previously	 shown	 in	 teleost	and	
mammalian	 lenses,	can	result	 in	both	a	 functionally	and	structurally	similar	 lens.	
Both	 mammalian	 and	 teleost	 lenses	 retain	 similar	 crystallin	 proteins	 (83,127),	
despite	demonstration	of	different	lens	precursor	structures	(Figure	1.3)	(87).		
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Recently,	 our	 group	 recently	 published	 a	method	 for	 purification	 of	 ROR1+	 LECs	
from	human	PS	cell	cultures	(108).	The	aim	of	the	work	in	this	Chapter	was	therefore	
to	test	whether	these	ROR1+	cells	could	be	used	to	generate	uniformly	sized,	non-
adherent	 light-focusing	 human	 lens	 tissue	 in	 vitro,	 suitable	 for	 lens	 toxicity	
screening	 and	 drug	 discovery.	 Therefore,	 aggregation	 of	 human	 PS	 cell-derived	
ROR1+	 lens	 cells	 into	 a	 ball-like	mass	 to	 replicate	 teleost	 lens	 development	was	
tested	 for	 production	 of	 functional	 human	 lens-like	 tissue	 in	 vitro	 (128).	 This	
approach	was	chosen	as	it	held	the	potential	to	generate	large	numbers	of	similarly-
sized,	 and	 similarly	 developmentally-staged	 micro-lenses	 suitable	 for	 high	
throughput	 drug	 screening.	 A	 commercial	 product,	 AggreWell,	 was	 used	 to	
aggregate	 the	 purified	ROR1+	 lens	 cells	 to	 replicate	 the	 teleost-like	 lens	 ball-like	
mass.	Using	an	AggreWell,	it	was	possible	to	generate	up	to	1200	similarly-sized	cell	
aggregates	at	once	within	each	well	of	a	24-well	plate.	
2.1.3 Lens generation requires a 3D culture environment 
Development	and	implementation	of	a	3D	growth	environment	is	a	vital	to	provide	
non-adherent	 support	 for	 aggregate	 to	 micro-lens	 growth.	 When	 cell	 culture	 is	
performed	on	a	2D	flat	culture	surface,	the	majority	of	the	surface	area	of	the	cell	is	
either	attached	 to	 the	 culture	vessel	or	exposed	 to	 the	medium	and	only	a	 small	
surface	area	of	each	cell	is	in	contact	with	surrounding	cells.	Cell-cell	signalling	is	
essential	 for	normal	 cellular	processes	 including	proliferation	and	differentiation	










culture,	 but	 less	 so	 in	 2D	 culture,	 therefore	 aggregates	 in	 3D	 culture	 may	 have	
greater	similarity	to	in	vivo	counterparts	(132).	
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A	 suitable	 3D	 growth	 environment	 must	 have	 several	 properties	 that	 allow	 for	
















cataract	 development,	 ophthalmological	 examinations	 of	 patients	 taking	 Vx-770	
were	recommended	by	the	manufacturer	(135)	and	recommendations	to	monitor	
ocular	health	were	made	during	 an	 efficacy	 and	 safety	 study	over	 long-term	use	
(136).	The	acknowledged	risk	of	developing	non-congenital	cataract	upon	exposure	
to	 Vx-770	 indicated	 that	 this	 drug	 was	 worthwhile	 investigating	 for	 cataract	
formation.	Many	of	the	patients	with	cystic	fibrosis	are	young	children,	for	whom	
development	 of	 a	 cataract	would	 have	 adverse	 social	 and	 developmental	 effects	
(18).		
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Exposure	of	 the	aggregated	 lens	cells	 to	clinically-relevant	doses	of	Vx-770	(137)	
during	their	developmental	period	may	enable	elucidation	of	induction	of	cataract	
by	this	drug.	Additionally,	candidate	drugs	that	are	known	to	cause	cataract,	such	as	
corticosteroids	 (39),	 or	 are	 associated	 with	 cataract	 could	 be	 utilized	 to	 induce	
cataract	 and	 validate	 a	 lens	 tissue	model.	Once	 it	 is	 known	 that	 cataract	may	be	
induced,	drugs	currently	considered	 to	 reverse	cataract	 (138,139)	may	be	 tested	
directly	 in	 a	human	 lens	model.	Measurement	of	 light	 transmission	and	 focusing	
ability	of	lens	organoids	could	form	a	quantifiable	assay	for	the	effect	of	drugs	on	
exposed	lens	organoids.		
The	 addition	 of	 a	 human	 lens	 organoid	 to	 other	 currently	 developed	 human	
organoid	 tissues	 could	 also	 benefit	 drug-screening	 applications.	 Intestinal	
organoids	were	used	to	test	the	effects	of	Vx-770	on	the	CFTR	gene	(CFTR	F508del)	




effects	may	be	 variable	between	different	 tissue	 types;	 determining	which	drugs	
benefit	one	system	but	damage	another	before	they	reach	clinical	trials	in	people	is	
an	ideal	outcome.		
The	 aims	 for	 this	 chapter	 include	 determination	whether	 human	PS	 cell-derived	
purified	ROR1+	LECs	can	be	aggregated	to	mimic	the	ball-like	mass	similar	to	teleost	
lens	development	and	generate	large	numbers	of	 functional	micro-lenses	 in	vitro.	
Additionally,	 such	 functional	 micro-lenses	 may	 be	 used	 to	 evaluate	 clinically-
relevant	drug-induced	lens	toxicity	by	assessing	the	effects	of	the	cystic	fibrosis	drug	




2.2.1 Reagents and consumables  
Reagents	 used	 for	 cell	 culture	 including	 mTeSR1,	 Dulbecco’s	 Modified	 Eagles	
Medium	 (DMEM),	 and	 Dispase	 (Cat	 no.	 07923)	 were	 acquired	 from	 Stem	 Cell	
Technologies	(Melbourne,	Australia).	Reagents	used	in	cell	harvesting	and	antibody	
staining,	including	TryPLE	Express	and	Dulbecco’s	Phosphate	Buffered	Saline	(PBS)	
(Gibco	 Life	 Technologies,	 Cat	 no.	 14190-250),	 were	 acquired	 from	 Invitrogen	
Corporation	(Mulgrave,	Australia),	unless	stated	otherwise.	Matrigel	to	coat	tissue	
culture	 plates	 was	 acquired	 from	 BD	 Biosciences	 (North	 Ryde,	 Australia).	 Rho-
kinase	 inhibitor	(ROCK	inhibitor)	(Merck,	Kilsyth,	Australia)	was	used	as	an	anti-
apoptotic	agent	during	cell	passaging	and	experiment	set	up.	DMEM:F12	(Thermo	
Fisher,	 North	 Ryde	 NSW,	 Cat	 no.	 11330-057)	 was	 the	 base	 medium	 for	 all	
differentiation	experiments.		
All	tissue	culture	plates	(6-well,	96-well,	35	mm	and	60	mm,	T175	flask)	and	pipette	
tips	 used	 for	 general	 cell	 culture	 were	 acquired	 from	 Greiner	 Bio-one	
(Frickenhausen,	 Germany).	 General	 laboratory	 equipment	 included	 light	
microscope	 (Olympus	 CKX41	 inverted	 microscope	 and	 accompanying	 digital	
camera	(Olympus,	Macquarie	Park,	Australia).	A	Beckman	Coulter	Allegra®	X	-	15R	
Centrifuge	 (Gladesville,	 Australia)	was	 used	 for	 volumes	 from	 1.5	mL	 to	 50	mL.	
Volumes	lower	than	1.5	mL	were	centrifuged	using	a	Beckman	Coulter	Microfuge	
22R	Centrifuge	or	QikSpin	Personal	Microfuge	(Edwards	Instrument	Co.,	Narellan,	






2.2.2 Human PS cell maintenance and harvest  
The	 human	 PS	 cell	 line	 CA1	was	 used	 (provided	 by	 Prof.	 Andras	Nagy,	 Toronto,	



















2.2.3 Generation of heterogeneous cell population 




noggin	 (Miltenyi	 Biotech,	 Cat	 no.	 130-103-456),	 1x	 N2	 supplement	 (Gibco	 Life	
Technologies,	 Cat	 no.	 17502-048)	 and	 1x	 B27	 (Gibco	 Life	 Technologies,	 Cat	 no.	
17504-044)	with	daily	medium	change	 for	6	days.	The	culture	medium	was	then	
changed	 to	 Stage	 2	 medium:	 DMEM:F12	 containing	 100	 ng/mL	 FGF2	 (Miltenyi	
Biotech,	Cat	no.	130-093-842),	20	ng/mL	BMP4	(Miltenyi	Biotech,	Cat	no.	130-098-
787)	and	20	ng/mL	BMP7	(Miltenyi	Biotech,	Cat	no.	130-103-436)	for	at	least	12	








Figure 2.1 Modified 3-step human PS cell differentiation process  
Schematic diagram showing the 3-stage process that induced PS cells towards the neuroectoderm fate 
then supplied growth factors that promote differentiation into lens cells. This process was modified so 
















no.130-091-376)	 and	 2	 mM	 ethylenediamine	 tetraacetic	 acid	 (EDTA).	 10	 μL	 of	
resuspended	cells	were	removed	for	a	cell	count.		
2.2.5 ROR1 antibody staining and MACS 
Biotinylated	antibody	was	prepared	in	advance.	Anti-ROR1	antibody	(R&D	Systems,	
Cat	no.	AF2000)	was	diluted	and	biotinylated	(Miltenyi	Biotech,	Cat	no.	130-093-











was	 removed	 and	 discarded,	 and	 the	 pellets	 resuspended	 in	 500	 μL	 cold	MACS	
buffer.		
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The	 cells	 were	 separated	 with	 the	 Miltenyi	 autoMACS	 Pro	 Separator	 (Miltenyi	
Biotec,	 Cat	 no.	 130-092-545)	 with	 positive	 selection	 program	 (Figure	 2.2).	 The	














Figure 2.2 AutoMACS separation of ROR1+ cells from lens cell mixture 
The heterogeneous cell mixture containing ROR1+ cells was mixed with biotinylated ROR1 antibody then 
anti-biotin microbeads. The mixture was passed through a magnetized column that retained labelled cells. 
The non-labelled cells were collected and discarded. The magnet is deactivated then the ROR1+ cells are 




2.2.6 Cell culture on silk fibroin and chitosan films 
The	 procedure	 for	 mixing	 and	 casting	 chitosan	 films	 was	 adapted	 from	 (135).	
Chitosan	 powder	 1.7	 %	 (by	 weight)	 (medium molecular weight, lot number 
MKBH1108V, average degree of acetylation, DA, of 24 % of monomer units and 
viscosity of 563 cP in 1 % acetic acid)	was	mixed	with	a	2	%	(by	weight)	acetic	acid	












handling	 during	 this	 process	 and	 was	 eliminated	 from	 further	 testing.	 5	 x	 105	
purified	ROR1+	cells	were	added	to	each	3mm	diameter	sections	of	chitosan	film,	
incubated	at	37oC	for	30	min	or	until	cells	attached	to	chitosan	film,	then	E3	medium	
was	 gently	 added	 to	 the	 culture	 vessel	 to	 submerge	 the	 chitosan	 films.	 Purified	
ROR1+	 cells	 were	 cultured	 on	 chitosan	 films	 from	 at	 least	 three	 separate	
differentiation	experiments	and	they	repeatedly	failed	to	attach	and	proliferate.		
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2.2.7 Harvesting ROR1+ cells and preparing aggregates  
Briefly,	AggreWell	plates	(Stem	Cell	Technologies,	Cat	no.	27845)	were	prepared	as	






2.2.8 Agarose embedding of ROR1+ aggregates 





heating	 in	 a	microwave	oven.	To	make	0.25%	 (w/v)	 agarose,	 3	mL	of	1%	 (w/v)	
agarose	was	added	to	the	pre-warmed	9	mL	M199,	in	the	biosafety	cabinet.	The	15	
mL	 tubes	were	 returned	 to	 a	 beaker	 of	 37oC	water	before	harvesting	 the	ROR1+	
aggregates	commenced.	The	agarose	did	not	exceed	37oC	at	the	time	of	embedding	
to	 prevent	 the	 potential	 of	 heat	 exposure	 to	 change	 protein	 structure	 or	 gene	
expression	of	the	aggregates.	
2.2.9 Harvesting and embedding ROR1+ aggregates  
The	aggregates	in	the	AggreWell	plate	were	gently	triturated	with	a	2	mL	pipette	
then	carefully	collected	and	placed	in	a	15	mL	tube.	Wells	were	washed	with	1	mL	
E3	medium,	 the	 collection	process	 repeated	 and	 the	medium	added	 to	 the	 tubes	
containing	the	aggregates.	The	aggregates	were	allowed	to	settle	via	gravity	for	10-
20	min.	The	supernatant	was	carefully	removed	leaving	the	calculated	volume	in	the	




to	 the	 final	 volume	 required	 in	 the	 aggregate-containing	 tube.	 To	 check	 the	
efficiency	of	the	settling	process,	the	removed	supernatant	was	placed	into	a	35	mm	
or	60	mm	dish	and	checked	under	the	microscope	for	aggregates.		







2.2.10 Measuring light transmission and light focusing 
ability 
The	aggregates	were	assessed	at	various	times	during	the	culture	period	for	light	










software,	 by	 quantifying	 approximately	 the	 central	 quarter	 diameter	 of	 the	
aggregate,	and	a	similar	measurement	taken	from	the	surrounding	media.	The	data	




2.2.11 Mass spectrometry analysis of micro-lenses 
Minimal	 sized	 segments	 of	 0.25%	 (w/v)	 agarose	 containing	 micro-lenses	 were	
mechanically	 separated	 from	 the	 remaining	 0.25%	 (w/v)	 agarose.	 The	 segments	





NH4HCO3	 added	 for	 protein	 digestion	 and	 placed	 in	 a	 heating	 block	 for	 16	 h,	 or	
overnight,	at	37	°C.		
The	peptides	were	purified	by	solid	phase	extraction	(SPE)	using	Waters	Oasis	HLB	
cartridges	 (Waters,	 Cat	 no.	 186003908).	 The	 cartridges	were	washed	with	1	mL	




TFA	 to	 remove	 salts	 then	 1	 mL	 ultrapure	 water	 to	 remove	 aqueous	 soluble	
unwanted	material	and	TFA.	Samples	were	eluted	with	500	μL	of	70%	(vol/vol)	ACN	
to	 650	 μL	 low	 binding	 collection	 tubes	 (Simport,	 Cat	 no.	 T330-6LST).	 ACN	 was	
evaporated	 from	 the	 collection	 tubes	 to	 dryness	 using	 rotational	 vacuum	
concentrator	(Christ	RVC	2-25	CD	plus)	for	3	h.	15	μL	of	0.1%	(vol/vol)	formic	acid	
was	 added	 to	 acidify	 peptide,	 rested	 for	 30	 min,	 triturated,	 then	 centrifuged	
(Dynamica	Velocity	14R)	for	10	min	at	20	290	x	g.	 
The	 formic	 acid	 solution	 containing	 the	peptides	was	 collected	 in	 glass	vials	 and	
analyzed	 by	 LC-MS/MS	 using	 a	 nanoAcquity	 UPLC	 and	 Xeno	 QtoF	 mass	











containing	micro-lenses	were	mechanically	 separated	 from	 the	 remaining	0.25%	
(w/v)	 agarose,	 embedded	 in	 2%	 (w/v)	 agarose	 and	 placed	 in	 tissue	 processing	
cassettes.	 The	 samples	 were	 dehydrated	 in	 a	 Micro	 STP-120	 Tissue	 Processor	
(Thermo	 Fisher	 Scientific)	 in	 50%	 (vol/vol),	 70%	 (vol/vol)	 and	 80%	 (vol/vol)	
ethanol	for	60	min	each	then	95%	(vol/vol)	and	100%	(vol/vol)	ethanol	for	2	x	90	
min	each,	xylene	for	3	x	90	min	then	paraffin	for	1	x	60	min	then	1	x	90	min.	Samples	
were	manually	 embedded	 in	 paraffin	 and	 cut	 into	 5	 μm	 thick	 sections	 using	 an	
Microm	HM325	microtome	before	being	mounted	on	glass	microscope	slides.	
The	following	solutions	were	prepared	for	immunofluorescence	analysis.	




















slide	 were	 used	 to	 guide	 separation	 of	 each	 section	 using	 hydrophobic	 solution	
provided	by	a	Pap	Pen	(Trajan	Scientific).	Sections	were	blocked	with	approximately	
100	 μL	 of	 10%	 (vol/vol)	 Normal	 Goat	 Serum	 (NGS)	 (Life	 Technologies,	 Cat	 no.	
50062Z)	for	10	min	at	room	temperature,	after	which	the	NGS	was	tapped	off	onto	
a	Kimwipe.	The	blocked	slides	were	placed	in	a	plastic	embedding	mould	inside	a	
small,	 sealable	 container	 lined	 with	 water-dampened	 sponges	 to	 create	 and	
maintain	a	humid	environment.	100	µL	of	diluted	primary	antibody	or	control	was	
added	to	each	section.	The	container	was	sealed	and	placed	in	the	4oC	cool	room	




anti-rabbit	 AlexaFluor488	 (Invitrogen,	 Cat	 no.	 A11078)	 secondary	 antibody	was	







were	 rinsed	 in	 35	mL	wash	 buffer	 in	 a	 foil-wrapped	 Coplin	 jar	 for	 10	min	 then	
mounted	gently	dried	by	tapping	on	to	a	Kimwipe	then	mounted	with	DPX	solution	
(Trajan	 Scientific,	 Cat	 no.	 1.00579.0500)	 before	 being	 imaged	 using	 a	 CKX41	
microscope	with	an	Olympus	ORFLT50	camera	and	Q	Capture	Pro	6.	



































added to 2mL stage 
3 medium  
( μL) 
0 0:1 50 0 2 
200 1:10 5 45 2 
500 1:4 12.5 37.5 2 
1000 1:2 25 25 2 
1500 3:4 37.5 12.5 2 




2.3.1 Generation of purified ROR1+ LEC cultures 









2.3.2 ROR1+ LEC aggregation to form thousands of teleost-





a	 silk	 fibroin	membrane	 (145,146).	Ultimately,	 the	 silk	 fibroin	did	not	withstand	
handling	 during	 Matrigel	 coating.	 The	 purified	 ROR1+	 cells	 did	 not	 attach	 or	
proliferate	 sufficiently	 to	 the	RGDS-grafted	chitosan	 films	 (data	not	 shown)	 for	a	
paired-explant	 type	 system	 to	 be	 a	 viable	 method	 in	 this	 case.	 Chitosan	 film	 is	
biocompatible	and	remains	a	suitable	substrate	for	future	investigation	of	lens	cell	
culture.	However,	work	to	improve	surface	and	peptide	grafting	homogeneity,	and	
biodegradability,	 was	 outside	 the	 focus	 of	 this	 thesis.	 Therefore,	 a	 different	








like	 aggregates	 appeared	 less	 dark	 under	 phase	 imaging	 than	 the	 surrounding	
agarose	3D	growth	environment	(Figure	2.4C).	This	simple	method	yielded	up	to	
1200	 aggregates	 per	 well	 of	 the	 AggreWell	 plate.	 By	 using	 several	 wells	








Figure 2.3 Generation of purified cultures of ROR1+ lens epithelial cells 
(A) human PS cell culture in Stage 2 medium on Day 13 showing variable-sized lentoids (arrowheads; 
ultimately lost from culture) and polygonal cells (asterisk, inset), comparable to those described in the 
published protocol (90,108). (B) Homogeneous population of tightly-packed polygonal LEC-like cells (inset; 






Figure 2.4 Aggregation of ROR1+ lens epithelial cells 
(A) Schematic diagram showing the aggregation and embedding step of ROR1+ cells into ball-like masses 
before initiation of Stage 3 of the lens cell differentiation protocol (90,108). (B) Aggregated ROR1+ cells 
(arrows) within micro-wells of an AggreWell plate showing the majority of input cells were incorporated 
into clearly-defined aggregates. (C) Low magnification image of ROR1+ aggregates (arrowheads) 






2.3.3 Maturation of aggregates into micro-lenses 
On	day	1	of	aggregate	culture	(i.e.,	the	day	of	embedding),	spheroidal	aggregates	of	
ROR1+	cells	(Figure	2.5A-E)	transmitted	less	light	than	the	surrounding	3D	growth	






















tested,	 immunofluorescence	 showed	 variable	 expression	 across	 the	 micro-lens	
(Figure	2.7C).	Immunofluorescence	analysis	confirmed	the	presence	and	location	of	
crystallin	proteins	detected	during	mass	spectrometry	analysis.	Analyses	of	other	
lens	 epithelial	 cell	 markers	 were	 outside	 the	 scope	 of	 this	 thesis.	 These	 data	
indicated	 that	 purified	 ROR1+	 LECs,	 when	 aggregated,	 can	 be	 induced	 to	 form	






Figure 2.5 Aggregated ROR1+ cells develop into light-transmitting micro-lenses with significant light 
focusing capacity 
(A-E) Light microscopy images taken at identical incremental distances below the aggregates on day 3 
post-aggregation demonstrated the aggregates transmitted less light than the culture medium (A) and 
possessed limited capacity to focus light (C). (F-J) Micro-lenses on day 27 typically transmitted equivalent 
levels of light compared to the culture medium (F) and focused light to an intense point (H). (K) 
Quantification of the increase in light transmission of the aggregates relative to the background on day 3 
and day 24. (L) Quantification of the increase in light focusing ability on day 3 and day 24. The 
representative images in Figure 2.5A-E and Figure 2.5F-J were the taken from the same aggregate at the 














Table 2.2 Micro-lens proteins identified by mass spectrometry 
Analysis by mass spectrometry identified α-crystallin in micro-lenses cultured in stage 3 medium at days 
7, 18 and 27; LF cell β-crystallins were identified at approximately day 18 and day 27. The number of 
peptides identified and the percent sequence coverage for example crystallin peptides are indicated (e.g. 
5, 28%, respectively). 
Lens proteins 
identified Day 7 Day 18 Day 27 
CRYAA 1, 6% 8, 30% 8, 35% 
CRYBB1 - 5, 28% 9, 34% 
CRBA1 - - 1, 6% 








Figure 2.6 Representative mass spectrometry data demonstrating micro-lenses express α-and β-
crystallin proteins 
 (A, B) MS/MS analysis showed 35% sequence coverage of CRYAA at day 18 (A), with example raw data 
peptide identification of sequence TVLDSGISEVR (A, underlined and B). (C, D) MS/MS analysis showed 39% 
sequence coverage of CRYBB1 at day 27 (C), with example raw data peptide identification of sequence 






















Figure 2.7 Cultured micro-lenses express LF cell-like crystallins 
(A-C, E-G) Immunofluorescence staining showed uniform expression of αA-crystallin (A) and β-crystallin 
(B) after culture in Stage 3 media for 24 days. Expression of γ-crystallin was detected by day 24 (C). Control 
immunofluorescence image showing non-specific staining (D). The corresponding images of DAPI-stained 











2.3.5 Treatment with Vx-770 reduced micro-lens function 
To	 test	whether	 the	micro-lens	 system	was	 suitable	 for	 drug	 toxicity	 assays,	 the	
developing	 micro-lenses	 were	 exposed	 to	 clinically	 relevant	 doses	 of	 Vx-770.	
Aggregates	were	dosed	in	the	range	of	0	ng/mL	(vehicle	only)	to	2000	ng/mL	which	
corresponds	 to	 the	 range	 of	 clinical	 doses	 of	 Vx-770	 in	 pediatric	 cystic	 fibrosis	
patients	(137).	After	23	days,	the	vehicle-only	treated	micro-lenses	(Figure	2.8A	to	
E)	had	developed	light	transmission	and	focusing	capability	similar	to	the	functional	
micro-lenses	 generated	 in	 stage	 3	media	 only	 (Figure	 2.5F	 to	 J).	 In	 contrast,	 the	













Figure 2.8 Development of micro-lens function is reduced by treatment with Vx-770 
(A to E) Representative images of a micro-lens treated with 0 ng/mL Vx-770 (vehicle only control ) for 23 
days of culture shows the aggregate developed similar light transmission (A) and focusing capability (C) to 
untreated micro-lenses (i.e., compared with Figure 2.5C). (F to J) Representative images of a micro-lens 
treated for 23 days with 2000 ng/mL Vx-770 shows the aggregate lost the defined-edge and did not 
develop light transmission (F) or focusing ability (H). (K, L) The response to Vx-770 was dose-dependent; 
micro-lenses developed light transmission ability (K) and focusing ability (L) with control and 200 ng/mL 









lens	 vesicle	 (125).	 That	 rat	 lens	 explant	 pair	 lens	 model	 demonstrated	 light	
transmission	and	focusing	ability	(125).	Furthermore,	a	cataract	developed	in	this	




the	 research	 required	 to	 improve	 the	 surface	 homogeneity	 and	 peptide	 grafting	
efficiency	 was	 outside	 the	 focus	 of	 this	 thesis,	 an	 alternative	 approach	 was	
investigated.	 Animal	models	 have	 been	widely	 used	 in	 cataract	 studies	 (22)	 and	
while	 they	 are	 useful,	 they	 are	 not	 human	 tissue.	 Indeed,	 there	 are	 differences	
between	 the	 cell	membrane	 composition	 of	 human	 lenses	 and	 those	 from	 other	
animals	(147)	as	well	as	growth	characteristics,	for	example,	human	lenses	have	a	
greater	proportion	of	growth	in	the	pre-natal	period	compared	to	other	species	(69).	




Differences	 in	 lenses	 between	 species	 are	 not	 limited	 to	 differences	 in	 crystallin	
expression	 and	 cell	 membrane	 composition.	 They	 also	 include	 the	 physical	
variations	of	lens	organogenesis.	For	example,	mammalian	lenses	arise	from	a	LEC-
lined	 vesicle	 and	 teleost	 lenses	 arise	 from	 a	 ball-like	 mass	 of	 LECs.	 By	 forming	
mammalian	cells	 into	a	 teleost-inspired	ball-like	mass,	human	micro-lenses	were	
produced	from	ROR1+	cells.	Thus,	mimicking	the	physical	pathway	of	 teleost	 lens	
development	 enabled	 production	 of	 uniform,	 light	 transmitting,	 light	 focusing	
human	micro-lens	tissue.	Developmental	studies	of	other	species	and	their	organ	
development	pathways	may	provide	further	insight	and	alternate,	perhaps	simpler,	
means	 of	 producing	 human	 PS	 cell-derived	 organoids	 for	 other	 (i.e.,	 non-lens)	
tissues	in	the	future.	





light	 focusing	or	 light	 transmitting	capacity	measured,	and	 they	were	not	 readily	





(91,93).	 Fu	 and	 colleagues	 (91)	 produced	 tens-to-hundreds	 of	 lentoids	 that	










interdigitations	 (108).	 These	 physical	 characteristics	 of	 micro-lenses	 generated	
within	 our	 laboratory	 were	 examined	 by	 electron	 microscopy	 and	 published	
(Appendix	A)	along	with	data	generated	by	myself	and	others,	however	analysis	of	
these	images	were	undertaken	by	others	and	thus	excluded	from	this	thesis	(108).		











regulatory	 networks	 and	 their	 controls,	 organelle	 loss	 and	 nuclear	 degradation	
during	lens	development,	which	have	typically	only	been	observed	in	non-human	
models.	These	human	PS	cell-derived	micro-lenses	are	 the	 first	of	 their	kind	that	
provide	 large	amounts	of	 in	vitro	human	 lens	 tissues	suitable	 for	 investigation	of	
development	and	for	drug	toxicity	screening.	
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2.4.3 Clinical utility of the micro-lenses 
Changes	 in	 light	 transmission	 and	 light	 focusing	 during	micro-lens	 development	
were	 measured	 in	 the	 micro-lens	 generation	 system	 described	 in	 this	 chapter.	
Initially	aggregated	ROR1+	cells	did	not	transmit	light	at	a	greater	intensity	than	the	
background	medium.	However,	after	culture	with	growth	factors	 that	 induced	LF	
cell	 development,	 the	 aggregates	 transmitted	 greater	 light	 than	 previously,	 and	
similar	 to	 that	 of	 the	 background	 medium.	 Likewise,	 light	 focusing,	 a	 key	





by	 reducing	 light	 transmission	 to	 the	 retina.	The	cystic	 fibrosis	drug	Vx-770	was	
chosen	to	model	cataract	formation	in	the	micro-lenses	as	it	is	suspected	of	causing	
cataract	 in	 young	 cystic	 fibrosis	 patients	who	 have	 received	 the	 drug	 (133,134).	
Diminished	vision	resulting	from	childhood	cataract	has	long-term	social,	emotional	
and	developmental	consequences	 (10).	An	 inability	 to	develop	 light	 transmission	
and	light	focusing	ability,	conceptually	similar	to	cataract,	was	induced	by	exposing	
aggregates	to	500	ng/mL	and	higher	doses	of	Vx-770	from	the	beginning	of	micro-




The	 micro-lenses	 could	 also	 provide	 a	 platform	 for	 further	 discovery	 of	 the	
molecular	 mechanisms	 of	 cataract	 caused	 by	 other	 risk	 factors,	 such	 as	
hyperglycemia	 (34)	 and	 smoking	 (149).	 For	 example,	 protein	 ageing	 and	
subsequent	instability	(150)	as	well	as	glycation	of	crystallins	(21,72)	are	postulated	
risk	factor	mechanisms	of	cataract	formation	that	could	be	investigated	using	the	
micro-lens	 system.	 Similarly,	 changes	 in	 protein	 aggregation	 or	 other	 post-
translational	 modifications	 (PTMs),	 such	 as	 methylation	 (42,151),	 could	 be	
identified.	 In	 turn,	 this	 could	 lead	 to	 investigation	 and	 development	 of	 potential	
patient-specific	(i.e.,	risk	factor-specific)	anti-cataract	drugs.	
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2.4.4 Limitations of the agarose 3D growth environment  
The	relative	simplicity	of	the	micro-lens	system	means	that	other	laboratories	can	
replicate	the	differentiation,	purification,	aggregation	and	embedding	protocols	and	
generate	 many	 thousands	 of	 micro-lenses	 for	 cataract	 research.	 The	 3D	 growth	
environment	 that	 agarose	 provided	 had	 several	 advantages	 for	 use	 as	 a	 first	
embedding	medium.	Agarose	is	inexpensive	and	readily	available;	it	did	not	require	
specialized	 equipment	 in	 order	 to	 produce	 the	 growth	 environment	 for	 the	
aggregates.	The	micro-lenses	were	supported	in	a	3D	growth	environment	allowing	
the	 spheroidal	 shape	 of	 the	 micro-lens	 to	 be	 maintained;	 this	 is	 difficult,	 if	 not	
impossible	to	maintain	if	aggregates	are	attached	to	a	hard	culture	plastic	surface	
(that	also	doesn’t	reflect	normal	lens	biology).	Moreover,	agarose	is	transparent	at	
the	 concentrations	 used	 here	 and	 thus	 allowed	 for	 quantification	 of	 light	
transmission	and	light	focusing	of	the	micro-lenses.		
In	 addition	 to	 these	 positive	 physical	 properties,	 the	 agarose	 gel	 conceivably	
provided	a	concentration	gradient	for	the	growth	factors	FGF2	and	Wnt3a	to	mimic	
the	 lens	 forming	gradient	 thought	 to	occur	 in	vivo	 (75).	Nevertheless,	 there	were	
some	inherent	difficulties	being	certain	that	this	was	the	case.	The	pore	sizes	within	
the	agarose	gel	were	almost	certainly	heterogeneous	and	it	could	not	be	certain	that	
a	 growth	 factor	 concentration	 gradient	was	 established.	 Additionally,	 harvesting	






limitations	 associated	 with	 this	 system.	 Firstly,	 the	 0.25%	 (w/v)	 agarose	 has	 a	




the	 aggregates	 risk	 clumping	 together	 or	 attaching	 to	 the	 culture	 surface	 before	
embedding	 is	 completed.	 Secondly,	 obtaining	 the	 correct	 temperature	 for	
embedding	 is	 challenging:	 if	 the	 agarose	 is	 too	 hot,	 it	 can	 cause	 damage	 to	 the	
aggregates,	for	example,	by	changing	the	tertiary	structure	of	α-crystallin,	or	gene	









process	 extremely	 time-consuming.	 Increasing	 the	 ratio	 of	 micro-lenses	 to	 3D	
growth	environment	would	be	advantageous.	This	can	be	achieved	in	either	of	two	
ways.	 The	 first	way	 is	 to	 increase	 the	 number	 of	micro-lenses	 in	 the	 3D	 growth	
environment	(which	risks	individual	micro-lenses	not	receiving	sufficient	nutrients	
or	 growth	 factors).	A	 second	approach	would	be	 to	 remove	part	or	 all	 of	 the	3D	









Chapter 3 Evaluation of an alternative 3D 
growth environment for micro-
lenses and assessment of ROR1-






3.1.1 Alternative 3D growth environments  









that	 nutrients	 and	 lens-inducing	 growth	 factors	 were	 accessible	 to	 ROR1+	 cells.	
Secondly,	some	challenges	were	noted	including	the	narrow	working	temperature	
range	during	embedding,	the	risk	of	contamination,	and	difficulties	upon	harvesting	















To	 both	 maintain	 the	 simplicity	 of	 the	 micro-lens	 system	 and	 ensure	 testing	 of	
quality	controlled	agarose	alternatives,	only	commercially-available	products	were	
assessed	 here.	 Numerous	 commercially-available	 hydrogel	 matrices	 have	 been	
reported	to	replicate	the	tissue	growth	environment	allowing	culture	of	tissues	in	a	
3D	 growth	 environment	 (152).	 Three	 commercially	 available	 hydrogel	 products	
were	 identified	 as	 potentially	 possessing	 the	 desirable	 criteria	 (Table	 3.1);	 the	
hyaluronic	 acid-based	 hydrogels	 HyStemC	 (Sigma	 Aldrich),	 HyStem	 +	 PEGSSDA	
(BioTime	 Inc)	and	 the	peptide-based	HydroMatrix	 (Sigma	Aldrich).	Each	of	 these	






3.1.2 More efficient generation of micro-lenses 
In	addition	to	finding	an	alternate	3D	growth	environment,	the	methods	associated	
with	 purification	 of	 the	 ROR1+	 cells	 retained	 some	 inefficiencies.	 While	 the	
published	 E3	 Medium	 stimulates	 proliferation	 of	 the	 ROR1+	 cells	 (108),	 large	




This	 raised	 the	 possibility	 that	 the	 time	 and	 cost	 of	 MACS	might	 be	 avoided	 to	
generate	enriched	(but	not	pure)	populations	of	ROR1+	cells	for	laboratory	(but	not	
clinical)	applications.	Accordingly,	this	chapter	investigates	possible	improvements	
to	 micro-lens	 production	 by	 culturing	 aggregates	 of	 ROR1-enriched	 cells	 in	






3.2.1 Reagents and consumables 
General	 cell	 culture	 reagents	 and	 consumables	 were	 as	 described	 in	 2.2.1.	
Additionally,	 the	 following	 reagents	 were	 used	 in	 the	 following	 experiments:	
HyStemC	with	 PEGSSDA	 linker	 kit	 (comprising	 EsiBio	 PEGSSDA	 0.5	mL,	 HyStem	
Glycosil,	 HyStem	 Gelin-S	 and	 Degassed	 (DG)	 water)	 (EsiBio,	 Alameda	 CA,	 USA),	
HydroMatrixTM	 (Sigma	 Aldrich,	 Castle	 Hill	 NSW,	 Australia),	 N-acetyl-L-cysteine	
(Sigma-Aldrich,	Cat	no.	A7250-5G).	
3.2.2 Human PS cell and ROR1+ cell culture  
Human	PS	cell	culture	methods	used	were	as	described	in	2.2.2.	Differentiation	to	




3.2.3 Commercial hydrogel assessment 






Figure 3.1 Assessment of commercial hydrogels for culture of ROR1-enriched aggregates 
Flow chart depicting the process to determine whether hydrogels met the requirements for culture and 
retrieval of ROR1-enriched aggregates. A number of candidate products were selected on the basis that 
they would support 3D culture of cells. The products could be used at varying concentrations, therefore 
the hydrogel concentration at which stiffness properties were compatible with daily media changes was 
determined. The suitable candidate hydrogel or hydrogels were dissociated following the recommended 
method. The hydrogel or hydrogels that met the selection criteria were selected for further testing with 







determine which hydrogel 
for further testing
proof-of-principle 
assessment of hydrogel with 
human PS cell aggregates


















tip	 and	 it	was	 noted	whether	 the	 blue	 tip	 penetrated	 and/or	 left	 a	mark	 on	 the	
hydrogel	surface.		
Ability	 to	 change	 media:	 to	 simulate	 cell	 culture	 medium,	 500	 μL	 of	 PBS	 was	
layered	 on	 top	 of	 a	 hydrogel	 without	 aggregates	 and	 incubated	 overnight.	 The	
following	 day,	 500	 μL	 of	 PBS	was	 removed	 and	 it	 was	 noted	whether	 complete	
medium	removal	occurred	without	disrupting	the	hydrogel	surface.		
Hydrogel	 dissociation:	 each	 hydrogel	 was	 dissociated	 according	 to	 the	
manufacturer’s	protocol.	Once	the	hydrogels	were	dissociated,	they	were	removed	














Table 3.1 Assessment criteria for commercial hydrogel 
Score Time to polymerise 
Rigidity of 
hydrogel 






+++ 5-10 min most rigid gel integrity retained complete dissociation in <30 min 
++ 10 – 20 min moderately rigid some disruption to edges of gel 
complete dissociation 
in 30-60 min 
+ 20-30 min rigid significant disruption to edges of gel 
incomplete or partial 
dissociation requiring 
additional PBS rinse 
- >30 min or did not set did not gel 
could not change 
media without 
removing significant 
amount of gel 
no dissociation or 
incomplete 
dissociation after 
additional PBS rinse 
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3.2.4 Preparation of HydroMatrix Peptide Cell Culture 
Scaffold 
HydroMatrix	has	a	pH	of	2.5	when	 in	aqueous	 solution	 (1%	w/v).	Consequently,	
isometric	(20%	w/v)	sucrose	is	needed	to	be	added	to	the	cells	to	be	encapsulated	




To	 generate	 the	 hydrogel,	 0.5	 mL	 sterile	 water	 was	 added	 to	 lyophilized	
HydroMatrix	 in	 an	 attempt	 to	 make	 a	 2%	 (w/v)	 solution.	 The	 product	 did	 not	







Table 3.2 Preparation of HydroMatrix hydrogel 
 
 0.25% 0.5% 1% 
HydroMatrixä stock solution (1% w/v) 75 uL 150 uL 300 uL 
water 225 uL 150 uL - 





3.2.5 Preparation of HyStem + PEGSSDA hydrogel 
HyStemC	 +	 PEGSSDA	 was	 prepared	 at	 concentrations	 recommended	 by	 the	
manufacturer	 and	at	 those	 found	 in	 literature	 for	 recovery	of	 cells	 for	metabolic	
analysis	 and	 CHiP	 sequencing	 (158).	 Following	 the	manufacturer’s	 protocol,	 the	
Glycosil,	and	Gelin-S	solution	were	prepared	by	dissolving	the	lyophilized	solid	in	1	
mL	 de-gassed	 (DG)	water,	 using	 a	 syringe.	 The	 vials	 were	 vortexed	 then	 placed	
horizontally	on	a	shaker	for	approximately	40	min	for	the	solids	to	disperse.	250	μL	
DG	water	was	added	to	PEGSSDA	to	make	a	2x	concentrated	solution.	All	solutions	
were	 kept	 on	 ice	 and	 used	 within	 2	 h	 of	 reconstitution.	 Gelin-S,	 Glycosil	 and	
PEGSSDA	were	combined	directly	in	wells	of	a	24	well	plate	in	the	amounts	stated	






Table 3.3 Preparation of HyStem + PEGSSDA hydrogel 
The HyStem + PEGSSDA was prepared to produce a range of concentrations. The amounts of each 
component used for each concentration is indicated below. 
 softest standard stiffest 
HyStemC with 
PEGSSDA A B C D E F 
gel concentration 
(%)(w/v) 0.25 0.5 1 2 4 6 
Glycosil (μL) 120 120 120 120 120 100 
Gelin-S (μL) 120 120 120 120 120 100 
DG water (μL) 56.25 52.5 45 30 0 0 
PEGSSDA (μL) 2x 
concentrate 










removed	 and	 placed	 in	 1	 well	 of	 a	 24-well	 plate	 to	 assess	 the	 completeness	 of	
dissociation	by	inspecting	for	presence	and	size	of	hydrogel	lumps	present,	if	any.	
3.2.6 Assessment of human ES cell aggregates in hydrogel 










Figure 3.2 Experiment plan for assessing micro-lenses derived from ROR1-enriched cell populations 
Three biological replicate cultures of ROR1-enriched cells were separately aggregated and plated in each 
0.25% (w/v) agarose and hydrogel before being exposed to Stage 3 medium (90) for 35 days. Aggregates 
were harvested on or near day 3, day 7, day 14 and day 35 for analysis by mass spectrometry. Light 
transmission and light-focusing measurements were taken on or near days 3, 7, 14, 28 and 36. Aggregates 












3.2.7.1 Preparation of ROR1-enriched lens cell aggregates in 
HyStem + PEGSSDA hydrogel 
ROR1-enriched	lens	cell	aggregates	were	prepared	as	described	in	section	2.2.6,	and	
plated	 in	 between	 2	 layers	 of	 6%	 (w/v)	 HyStem	 +	 PEGSSDA	 with	 added	
concentrated	E3	medium	mixture.	The	E3	concentrate	was	added	 to	yield	a	 final	
concentration	 in	 the	 hydrogel	 equivalent	 to	 E3	ROR1+	 cell	maintenance	medium	
(section	2.2.5).	GelinS	and	Glycosil	were	made	with	1	mL	of	DG	water.	PEGSSDA	was	
made	to	a	2x	concentration	with	250	μL	DG	water.	The	GelinS,	Glycosil	and	PEGSSDA	




an	 incubator	 for	60	min	at	37°C,	5%	(vol/vol)	CO2	 in	order	 for	 the	base	 layer	 to	
completely	polymerise.		
ROR1-enriched	aggregates	were	prepared	as	described	in	section	2.2.6.	Using	a	2	














3.2.7.2 Preparation of ROR1-enriched aggregates in 0.25% 
agarose 
ROR1-enriched	 aggregates	were	 prepared	 as	 described	 in	 section	 2.2.5.	 Samples	
were	collected	on	or	near	days	3,	7,	14	and	36	for	analysis	by	mass	spectrometry.	
The	 collected	 samples	 of	 0.25%	 (w/v)	 agarose	 containing	 the	 aggregates	 were	
homogenized	with	a	plastic	micro-pestle,	directly	in	a	1.5	mL	Eppendorf	tube	before	
addition	of	Rapi-Gest	 and	 the	 samples	were	processed	 for	mass	 spectrometry	as	





3.3.1 Assessment of commercial hydrogel physical 
properties  
As	a	first	step	to	determining	the	suitability	of	the	3	hydrogels	for	micro-lens	culture,	
their	 aggregation	 and	 dissociation	 characteristics	 were	 assessed.	 Dissociation	 of	














As	 micro-lens	 culture	 currently	 requires	 daily	 medium	 changes,	 both	 HyStem+	
PEGSSDA	 concentrations	 were	 assessed	 for	 their	 mechanical	 strength	 via	 their	
ability	to	withstand	medium	changes.	This	involved	looking	under	the	microscope	
and	tilting	or	shaking	the	24	well	plate	in	addition	to	determining	whether	a	blue	tip	








Table 3.4 Assessment of commercial hydrogels at varying concentrations 
The hydrogels were assessed according to the criteria described in (3.2.3). 
	
	
 HyStem + PEGSSDA HydroMatrix 
hydrogel 
% (vol/vol) 
0.25 0.5 1 2 3 4 6 0.25 0.5 1 
  Time taken 
to polymerise 
(min) 
















- - - - + + ++ - - - 
Dissolution 




no no no no no yes yes no no no 
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An	 additional	 desirable	 hydrogel	 property	 is	 the	 capacity	 to	 easily,	 quickly	 and	
cleanly	 dissociate	 and	 release	 the	 micro-lens	 tissues.	 This	 would	 facilitate	
downstream	 analyses	 such	 as	 mass	 spectrometry	 and	 gene	 expression	 analysis	








the	 basis	 of	 these	 data,	 4%	 and	 6%	 (vol/vol)	 HyStem	 +	 PEGSSDA	 were	 the	
commercially	available	hydrogels	chosen	for	subsequent	experiments.	
3.3.2 Assessment of human PS cell aggregates in hydrogel 
To	test	the	permeability	of	the	4%	and	6%	(w/v)	HyStem	+	PEGSSDA	of	hydrogels	
for	embedding	aggregates,	a	pilot	test	using	human	PS	aggregates	was	performed	




therefore	 4%	 (w/v)	 HyStem	 +	 PEGSSDA	 was	 deemed	 unsuitable	 for	 culture	 of	




(w/v)	HyStem	+	PEGSSDA	was	assessed	 to	have	 the	most	 suitable	properties	 for	
continuing	with	the	time	course	experiments	using	ROR1-enriched	cells.		
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3.3.3 Comparison of hydrogel and 0.25% agarose with 
ROR1-enriched cell aggregates 
In	 order	 to	 adequately	 compare	 the	 6%	 (w/v)	 HyStem	 +	 PEGSSDA	 hydrogel	 to	
agarose	 for	 micro-lens	 culture,	 aggregates	 of	 ROR1-enriched	 cells	 (rather	 than	
MACS-purified	ROR1+	cells)	were	embedded	in	both	3D	growth	environments	and	
cultured	 in	 parallel.	 Three	 biological	 replicate	 experiments	 were	 completed	 and	
compared	under	the	same	incubation	conditions	and	media	changes.	The	aggregates	




and	 no	 MACS	 displayed	 a	 homogeneous	 distribution	 of	 polygonal	 shaped	 cells,	








Figure 3.3 ROR1-enriched cells are morphologically similar to ROR1+ cells 
Day 7 (A) ROR1-enriched cells in a confluent monolayer appear homogeneous and possess the polygonal 













The	 previously	 defined-edged	 aggregates	 had	 lost	 edge	 definition	 and	 formerly	
aggregated	cells	appeared	to	detach	from	one	another	(Figure	3.4B,	E,	G).	By	day	7	
(Figure	 3.4F)	 no	 aggregates	 in	 HyStem	 +	 PEGSSDA	 remained	 intact.	 This	 loss	 of	
aggregates	 was	 repeatable,	 and	 was	 observed	 in	 all	 three	 biological	 replicate	
experiments	 performed	 using	 HyStem	 +	 PEGSSDA	 (Figure	 3.4G).	 Ultimately,	 the	
HyStem	+	PEGSSDA	cultured	ROR1-enriched	aggregates	were	discarded	on	day	7	
after	 embedding	 as	 there	 were	 no	 viable	 aggregates	 remaining	 by	 that	 time.	
Consequently,	 no	 further	 analyses	 were	 able	 to	 be	 performed	 on	 the	 HyStem	 +	
PEGSSDA	 aggregates.	 In	 contrast,	 the	 majority	 of	 ROR1-enriched	 aggregates	






Figure 3.4 ROR1-enriched aggregates did not survive in HyStem + PEGSSDA hydrogel 
(A-C) ROR1-enriched aggregates embedded in 0.25% agarose at day 1 (A), day 3 (B) and day 7 (C) retained 
defined edges throughout the culture period indicative of live cells being present up to (and beyond) day 
7 (C). (D-F) ROR1-enriched aggregates embedded in HyStem + PEGSSDA hydrogel at day 1 had defined 
edges. By day 3, the aggregates appeared as clusters of dead cells (E, arrowheads, inset) and aggregate 
loss continued through to day 7 (F). (G) The loss of aggregates over this time was significant at each time 








3.3.4 Aggregated ROR1-enriched cells developed lens-like 




light	 transmission	 and	 light	 focusing	 data	were	 analysed	 using	 the	 Kolmogorov-
Smirnov	 test	and	were	 found	 to	be	normally	distributed	 then	analysed	using	 the	
Student’s	t-test.	In	some	cases	it	was	higher,	likely	due	to	the	size	of	the	aggregates	
causing	 a	 focusing	 effect	 beginning	when	 the	micro-lens	 periphery	was	 in	 focus.	
Additionally,	by	day	28	the	ROR1-enriched	micro-lenses	had	developed	significant	
focusing	ability	(Figure	3.6L).		
Interestingly,	 by	 7	 days	 after	 embedding,	 the	 agarose-cultured	 ROR1-enriched	
aggregates	had	started	to	develop	light	transmission	levels	close	to	the	surrounding	
culture	medium	(Figure	3.4B,	C	and	Figure	3.7K).	This	was	earlier	than	the	purified	
ROR1+	 aggregates	 described	 in	 Chapter	 2,	 where	 the	 light	 transmission	 reached	













Figure 3.5 ROR1-enriched micro-lenses developed protrusions  
Light microscopy images showed that ROR1-enriched cell aggregates had clearly defined edges at day 3 
(A). On day 14 there was evidence of formation of small protrusions on some aggregates (arrowhead, B). 
By day 28 numerous aggregates had formed protrusions (arrowheads, C). The majority of micro-lenses 
had formed protrusions by day 36. Day 28 micro-lenses retained their defined-edge core regardless of 
protrusion development (E-H). Protrusions were variable in size and position relative to the micro-





Figure 3.6 Aggregated ROR1-enriched cells develop micro-lens properties 
Light microscopy images taken at increasing distances below the aggregates (A to E) on day 3 of culture 
show the initial low light transmission properties of the aggregates (A) and inability to focus light (C). (B 
to E) By day 28, the agarose-embedded ROR1-enriched micro-lenses transmitted light at least equal to 
the surrounding culture medium (F) and also had developed significant light-focusing ability (H). (K) 
Developing micro-lenses initially transmitted less light relative to the background medium at day 3, then 
more by day 28 (p<0.05). (L) The micro-lenses gain light focusing ability (position 3) and transmitted 
increased light (position 1) at day 28 compared to day 3 of culture and the surrounding culture medium. 






Figure 3.7 ROR1-enriched aggregates focus light 7 days after embedding in agarose  
Light microscopy images taken at incrementally increasing distances below the aggregates (A to E) on day 
3 of culture showed the initial low light transmission properties of the aggregates (A) and inability (C) to 
focus light. (F to J). By day 7, the micro-lens transmitted more light (F) and became able to focus light to 
a point (H). (K) Developing micro-lenses initially transmitted less light relative to the background medium 
at day 3, then equal to the background from day 7 onwards (p<0.05). (L) By day 7, the micro-lenses gain 
light focusing ability (position 3) and could transmit similar levels of light compared to the background 




3.3.5 Aggregated ROR1-enriched cells expressed crystallin 
proteins 
To	assess	 the	molecular	 changes	occurring	 in	 the	ROR1-enriched	aggregates,	 the	
presence	 and	abundance	of	 lens	proteins	was	 ascertained	by	mass	 spectrometry	
(Figure	3.8,	Figure	3.9).	β-crystallin	was	detected	at	all	time	points,	suggesting	that	
immature	 LF-like	 cells	 were	 present	 in	 the	 ROR1-enriched	 lens	 cell	 culture.	 In	
contrast,	micro-lenses	at	day	8	from	purified	ROR1+	cells	did	not	express	β-crystallin	
(Section	2.3.4).	The	mass	spectrometry	analysis	also	revealed	a	trend	of	increasing	


















Figure 3.8 Sequence coverage of lens proteins identified by mass spectrometry 
All proteins had greater sequence coverage on day 36 than day 3. All identified crystallins demonstrated 
a greater sequence coverage at day 36 than on day 3 after embedding. The increase in sequence coverage 
was significant (asterisk) for CRYAA, CRYBA1, CRYBA4, CRYBB2, and CRYBB3 (p<0.05). Interestingly, CRYGC 
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Figure 3.9 Proteins identified in ROR1- enriched micro-lenses by mass spectrometry 
(A) MS/MS analysis showed 30% sequence coverage of CRYAA at day 36, with (B) example raw data 
peptide identification of sequence TVLDSGISEVR (A, underlined). (C) MS/MS analysis showed 89% 
sequence coverage of CRYBB1 at day 7, with example raw data peptide identification sequence 














alteration	 of	 transcription.	 Evaluation	 of	 3	 commercially-available	 hydrogels	
identified	 6%	 HyStem	 +	 PEGSSDA	 as	 the	 only	 one	 with	 this	 range	 of	 required	
properties.	 Despite	 this	 testing,	 including	 overnight	 assessment	 of	 CA1	 cell	
aggregates,	6%	HyStem	+	PEGSSDA	did	not	support	longer-term	survival	of	ROR1-
enriched	aggregates.	
This	 failure	of	 the	HyStem	+	PEGSSDA	occurred	despite	 identical	 incubation	and	
media	conditions	used	for	the	embedded	aggregates	set	up	and	cultured	alongside	
the	 HyStem	 +	 PEGSSDA	 aggregates.	 The	 manufacturer’s	 highest	 recommended	
concentration	was	4%	(w/v);	however,	this	hydrogel	was	successfully	used	at	6%	
(w/v)	 for	 3D	 culture	 of	 stromal	 cell	 spheroids	 (158).	 The	 6%	 (w/v)	 HyStem	 +	
PEGSSDA	 was	 the	 only	 hydrogel	 concentration	 that	 met	 the	 mechanical	
requirements	for	daily	media	changes;	however,	the	permeability	of	the	hydrogel	to	








3.4.2 ROR1-enriched cells produced light-focusing micro-
lenses at an early time point  
ROR1-enriched	cells	appeared	to	be	a	phenotypically	homogeneous	population	of	
cells,	phenotypically	similar	to	purified	ROR1+	cells.	Despite	the	failure	of	the	6%	
HyStem	 +	 PEGSSDA	 to	 support	micro-lens	 development,	 the	 agarose-based	 data	
demonstrates	 that	 ROR1-enriched	 aggregates	 develop	 micro-lens	 properties.	







LEC	 populations	 for	 research	 applications.	 Notably,	 ROR1-enriched	 cells	 are	
unlikely	 to	be	suitable	 for	clinical	applications	due	 to	 their	reduced	homogeneity	
compared	to	purified	ROR1+	cells.		
The	 use	 of	 ROR1-enriched	 cells	 makes	 generation	 of	 tens-of-thousands	 of	 light-
focusing	micro-lenses	simpler	and	more	cost-effective	compared	to	purified	ROR1+	
cells	 for	 laboratory-only	 investigation	 of	 cataract	 and	 for	 drug-toxicity	 assays.	
However,	the	ROR1-enriched	aggregates	frequently	developed	protrusions	after	14	
days	 in	 culture	 (Figure	 3.5B).	 While	 some	 minor	 bleb-like	 protrusions	 were	
observed	 in	 purified	 ROR1+	micro-lenses	 produced	 in	 our	 laboratory	 (108),	 the	









3.4.3 Future directions using ROR1-enriched micro-lenses 
The	 ROR1-enriched	micro-lens	 culture	was	more	 efficient	 and	 less	 expensive	 to	
produce	than	purified	ROR1+	micro-lenses.	The	MACS	process	yielded	an	average	
10	 to	 20%	of	 purified	ROR1+	 cells	 from	a	 starting	ROR1-enriched	 (strained	 cell)	
population	e.g.,	30	x	106	ROR1-enriched	cells	would	produce	3	to	6	x	106	purified	
ROR1+	cells.	The	ROR1-enriched	cell	yield	was	 typically	80%	ROR1-positive	cells	




anti-ROR1	 antibody	 as	 well	 as	 other	 MACS	 reagents	 –	 thereby	 making	 ROR1-
enriched	micro-lens	production	more	cost-effective.	Overall,	efficiency	is	increased	
and	 the	ROR1-enriched	aggregates	 enable	 less	 expensive	 and	 larger-scale	micro-
lens	production	compared	 to	 the	same	 timeframe	using	purified	ROR1+	cells,	 yet	









Chapter 4 General discussion 
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4.1 Overview of thesis outcomes: Generation of 
functional in vitro human micro-lenses for 
investigating cataract 
Cataract	 is	 a	 widespread	 issue	 and	 leading	 cause	 of	 low	 vision	 and	 blindness,	
decreasing	the	quality	of	life	for	tens-of-millions	of	people	worldwide	(2).	Treatment	
for	cataract	involves	removal	of	cataractous	lens	cells,	followed	by	implantation	of	
an	 IOL	 to	 replace	 lens	 function.	 With	 millions	 of	 cataract	 surgeries	 performed	
worldwide	each	year,	 the	overall	 cost	of	 current	surgical	 treatment	of	 cataract	 is	
expensive.	 It	 also	 requires	 highly	 specialized	 equipment	 that	 can	 be	 difficult	 to	
access	for	millions	of	cataract	sufferers	in	developing	countries	(7,9).	Clinical	trials	
are	yet	to	identify	any	effective	drug	or	vitamin	capable	of	delaying	cataract	(161).	
In	order	 to	develop	alternative	 treatments	 for	cataract,	 the	underlying	molecular	
mechanisms	of	cataract	formation	must	be	identified	and	understood.	Animal	lens	
models	have	assisted	in	understanding	some	aspects	of	cataract;	however,	they	do	
not	 truly	 represent	 the	 human	 lens	 in	 terms	 of	 cell	 membrane	 composition	 or	
protein	expression.		
Previously	 published	 research	 demonstrated	 that	 heterogeneous	 cultures	
containing	lens	cells	and	non-lens	cells	can	be	generated	from	human	PS	cells,	with	
lens	cells	randomly	organized	in	microscopic	(90)	or	macroscopic	(91)	structures	
called	 ‘lentoids’.	However,	 these	 approaches	 had	 significant	 limitations	 including	
the	 inability	 to	 produce	 uniformly-sized	 lens-like	 structures	 and	 limited	 or	 no	







shown	 that	 development	 of	 LF	 cells	 within	 the	 micro-lenses	 included	
morphologically	recognizable	milestones	including	organelle	loss	and	denucleation	
(108).	 These	 results	 suggest	 that	 mimicking	 non-human	 development	 patterns	
might	be	a	useful	way	of	generating	other	tissue	types	from	human	PS	cells.		
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As	 noted	 in	 the	 thesis,	 there	 were	 limitations	 to	 culturing	 the	 ROR1+	 LECs	 on	







lens	assay.	Greater	efficiency	 in	 terms	of	both	 lower	cost	and	higher	cell	number	
yield	 in	 a	 given	 timeframe	 was	 achieved	 through	 use	 of	 ROR1-enriched	 cells	
(obtained	via	filtration	through	a	40	µm	cell	strainer	without	MACS).	
An	 attempt	 to	 further	 simplify	 the	 micro-lens	 system	 by	 assessment	 of	 several	
commercially-available	 hydrogels	 as	 potential	 agarose	 replacements	 was	
unsuccessful.	 This	 is	 perhaps	 unsurprising	 given	 that	 the	 field	 of	 embedding	




of	 light	 transmission	 and/or	 focusing	 ability,	 suggesting	 the	 micro-lenses	 are	
suitable	for	clinically-relevant	studies	of	the	mechanism	of	cataract	formation	and	
as	a	tool	for	investigating	lens	toxicity.	Moreover,	the	equipment	required	for	micro-




4.2 General implications and contribution to lens 
research 
4.2.1 Investigation of risk factors 
The	 ability	 to	 detect	 Vx-770-induced	 cataract	 suggests	 that	 exposure	 of	 human	
micro-lenses	 to	 known	 cataract	 risk	 factors	 could	 reveal	 some	 of	 the	molecular	
mechanisms	 of	 cataract.	 Changes	 previously	 associated	 with	 different	 types	 of	
cataractous	human	or	animal	lenses,	include	abnormal	cellular	morphologies	(e.g.,	
swelling),	proliferation,	migration	and/or	differentiation;	multi-lamellar	bodies;	as	
well	 as	 breakdown,	 proteolysis	 and/or	 PTM	 of	 crystallin	 proteins	 (e.g.,	 non-
enzymatic	methylation	 of	 cysteine	 and	 arginine	 residues	 from	 the	metabolic	 by-
product	 S-adenosyl	methionine,	 isomerization,	 cross-linking,	 oxidation,	 advanced	
glycemic	 end-products,	 deamidation,	 racemization	 and	 isomerization)	
(31,149,163,164).	 A	 variety	 of	 cataract	 risk	 factors	 have	 also	 been	 identified;	







used	 to	 guide	 time-point	 collection	 for	 molecular	 analyses	 (e.g.,	 genomics,	
transcriptomics,	proteomics,	metabolomics	etc.).	
For	example,	diabetes	is	associated	with	up	to	five-fold	increased	cataract	risk	(46).	
Diabetic	 cataract	 can	 present	 as	 cortical	 and/or	 posterior	 subcapsular	 cataract	
(46,165);	however,	 increased	 light	scatter	has	been	observed	 in	human	 lenses	of	
diabetic	patients	 in	 the	absence	of	 visually	observable	 cataract	 (166).	A	 range	of	
changes	thought	to	be	related	to	diabetes	have	been	noted	in	the	lenses	of	various	
species	and	include:	osmotic	swelling,	decreased	glutathione	levels,	increased	levels	
of	 oxidized	 glutathione,	 increased	 lipid	 peroxidation	 and	 PTM	 of	 crystallins,	
including	 advanced	 glycation	 end-products	 (some	 of	 which	 may	 result	 in	
brunescence)	 (23,29,46)	 (166-168).	Notably,	while	 an	 aldose	 reductase	 inhibitor	
(Kinostat)	has	recently	been	approved	as	an	effective	treatment	of	cataract	in	dogs	
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(169),	 it	 appears	 unlikely	 to	 be	 a	 successful	 treatment	 for	 human	 cataract.	 The	
micro-lens	 system	may	 therefore	provide	an	opportunity	 to	understand	whether	







Additional	 risk	 factors	 of	 cataract	 could	 be	 tested	 in	 a	 similar	 manner.	 Other	
proposed	 cataract	 risk	 factors	 include	 exposure	 to	 hyperbaric	 oxygen.	 This	 is	







ions	 in	 smokers;	 however,	 the	 relationship	 these	 have	 to	 cataract	 is	 unknown	
(33,173)	 but	 could	 be	 investigated	 using	 the	 micro-lens	 systems.	 Significant	
increases	 in	 Cd,	 Se	 and	 a	 reduction	 in	 Cu	 ions	 are	 age-related	 (33)	 and	Cd	 is	 an	
inducer	 of	 oxidative	 stress	 (23).	 Exposing	 micro-lenses	 to	 these	 metal	 ions,	 at	
relevant	 concentrations,	 may	 be	 utilized	 to	 investigate	 their	 relationships	 to	
cataract.	An	alternative	hypothesized	mechanism	for	smoking-related	cataract	is	by	
accumulation	 of	 p-benzoquinone	 (a	 compound	 associated	with	 cigarette	 smoke-
related	pathogenesis)	in	the	lens	that	may	induce	αA-crystallin	aggregation	(173).	
Finally,	cholesterol-lowering	statin	use	has	a	controversial	association	with	cataract	
risk	 (39,174,175)	 and	 controlled	 in	 vitro	 assessment	 could	 assist	 determining	
whether	there	is	an	association	between	statin	exposure	and	cataract.		
Should	cataract	within	the	micro-lenses	be	induced	by	any	of	the	above	risk	factors,	
then	 targeted	 analyses	 could	be	performed	 throughout	 onset	 and	progression	of	
cataract	to	define	how	cataract	formation	occurs.	Once	the	molecular	mechanisms	
are	elucidated	 for	cataract	 risk	 factors,	 this	could	 lead	 to	 i)	 identification	of	non-
invasive	 biomarkers	 of	 diabetic	 (or	 other)	 cataract	 (that	 precede	 vision	 loss),	 ii)	
identification	 of	 drug-able	 targets	 for	 diabetic	 (or	 other)	 cataract,	 and	 iii)	 a	






4.2.2 Toxicity screening 
The	exposure	of	developing	micro-lenses	to	the	drug	Vx-770	demonstrated	a	dose-





cataract	 potential,	 by	 measuring	 changes	 in	 micro-lens	 light	 transmission	 and	
focusing.	 For	 example,	 drugs	 that	 have	 previously	 demonstrated	 formation	 of	
cataract	 such	 as	 corticosteroids	 (39),	 or	 are	 associated	 with	 cataract	 like	
antipsychotics,	such	as	clozapine	(176,177)	may	be	screened	using	human	micro-
lenses	 to	 determine	 whether	 these	 drugs	 induce	 cataract	 in	 human	 lens	 tissue.	





4.2.3 Investigation of genetic causes of cataract 
The	micro-lens	 system	could	be	applied	using	ROR1+	 cells	derived	 from	disease-
specific	ES	or	iPS	cells.	This	would	allow	production	of	micro-lenses	for	investigation	
of	genetic	 cataract	 (32)	or	other	diseases	 that	affect	 the	 lens,	 for	example	Alport	
syndrome	(74).	Mutations	can	occur	in	crystallin	genes,	lens	cytoskeletal	genes,	lens	
membrane	protein	genes,	or	genes	for	lens	transcription	factors	such	as	PAX6	(178).	
Production	 of	 thousands	 of	 uniform	 human	micro-lenses	 could	 transform	 future	
cataract	 research	 by	 providing	 an	 investigative	 platform	 for	 research	 into	 these	
genetic	sight-affecting	diseases	of	the	lens	by	producing	a	disease-in-a-dish	model	






which	 genes	 are	 switched	 on	 and	 switched	 off	 during	 early	 lens	 development,	
commencement	of	the	OFZ	in	humans	and	the	key	time	points	in	which	the	stages	
occur	 can	 be	 examined.	 Risk	 factors	 for	 cataract	 can	 be	 tested	 and	 molecular	
mechanisms	elucidated,	in	a	human-specific	model.	Likewise,	preventative	and/or	















































































































































































































































































































































































































































































































































































Appendix A Publication  
 
Light-focusing human micro-lenses generated from pluripotent 
stem cells model lens development and drug-induced cataract in 
vitro  
Patricia	 Murphy*,	 Md	 Humayun	 Kabir,*,	 Tarini	 Srivastava,*,	 Michele	 E.	 Mason*,	
Chitra	 U.	 Dewi,	 Seakcheng	 Lim,	 Andrian	 Yang,	 Djordje	 Djordjevic,	 Murray	 C.	
Killingsworth,	Joshua	W.	K.	Ho,	David	G.	Harman	and	Michael	D.	O’Connor.	
*equally	contributing	authors	
